RA34 Pill - yellow oval, 11mm
Pill with imprint RA34 is Yellow, Oval and has been identified as Pantoprazole Sodium Delayed-Release 40 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Pantoprazole is used in the treatment of Barrett's Esophagus; Erosive Esophagitis; Duodenal Ulcer; GERD; Gastritis/Duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RA34
Pantoprazole Sodium Delayed-Release
- Imprint
- RA34
- Strength
- 40 mg
- Color
- Yellow
- Size
- 11.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC)
- 63304-0968
- Inactive Ingredients
-
calcium stearate,
crospovidone,
ferric oxide yellow,
hydroxypropyl cellulose,
hypromelloses,
ferrosoferric oxide,
mannitol,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
povidone,
propylene glycol,
shellac,
sodium carbonate,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
More about pantoprazole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (428)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: proton pump inhibitors
- Breastfeeding
Patient resources
- Pantoprazole drug information
- Pantoprazole (Intravenous) (Advanced Reading)
- Pantoprazole Delayed-Release Tablets
- Pantoprazole Delayed-Release Granules
- Pantoprazole Injection
Other brands
Professional resources
- Pantoprazole Sodium monograph
- Pantoprazole (FDA)
- Pantoprazole Granules (FDA)
- Pantoprazole Injection (FDA)
- Pantoprazole Oral Suspension (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.